The Economist: Blasted are the dealmakers
A study co-authored by Geoff Meeks, Emeritus Professor of Financial Accounting at Cambridge Judge Business School, and J. Gay Meeks, Senior Research Associate in the Centre of Development Studies, University of Cambridge, is mentioned in this article about firms’ unwise…
Financial Times: Mergers destroy value. Without reform, nothing will change
Geoff Meeks, Emeritus Professor of Financial Accounting at Cambridge Judge Business School, and J Gay Meeks, Senior Research Associate at the University of Cambridge Centre of Development Studies, write about mergers and acquisitions. It’s an often-quoted statistic that roughly 70…
New book asks why ever more is spent on mergers when so many fail
Mergers are constructed by talented executives, lawyers, bankers and advisers, yet most deals fail. A new book The Merger Mystery, co-authored by Geoff Meeks of Cambridge Judge Business School, outlines the reasons why. Mergers of firms have boomed over the…
It all began at Cambridge Judge
Twenty-five years ago, an Argentinian, an American and an Australian met on the Cambridge MBA programme and have continued to work and invest together ever since. Twenty-five years ago, Enrique Klix (MBA 1997) from Argentina, Lynne Thornton (MBA 1997), nee Braddick,…
Why acquirers retain tech startup CEOs
Acquirers are more likely to retain a young tech firm’s CEO if they are a founder owing to their ‘pivotal’ role in deal implementation, finds a study co-authored at Cambridge Judge Business School. Dr Keivan Aghasi According to much conventional…
The rise of the special purpose acquisition company
by Dr Sunwoo Hwang, Research Associate, Cambridge Centre for Finance and Cambridge Endowment for Research in Finance 2020 has been the year of special purpose acquisition companies or SPACs. A SPAC is a blank check shell company designed to take…
Cambridge Network: Study examines cultural fit in big pharma integration
Piyush Durani, an Executive MBA graduate of Cambridge Judge (EMBA 2018), measures cultural fit in the $74 billion merger of Bristol-Myers Squibb and Celgene. “As I progressed through my EMBA programme in 2018-2019, the BMS acquisition of Celgene was announced…
Big pharma
Piyush Durani, an Executive MBA graduate of Cambridge Judge (EMBA 2018), measures cultural fit in the $74 billion merger of Bristol-Myers Squibb and Celgene. Piyush Durani The well-known business expression "culture eats strategy for breakfast" is particularly apt for mergers…
Food fight
Shopping trends mean blocking the big Sainsbury's-Asda merger may not protect customers, says Professor Yasemin Kor of Cambridge Judge Business School. Professor Yasemin Kor The proposed merger of supermarkets Sainsbury's and Asda is now off the table as the regulator has…
The Conversation: Shopping trends mean blocking the big Sainsbury’s-Asda merger may not protect customers
Yasemin Kor, Beckwith Professor of Management Studies at Cambridge Judge, discusses the blocking of the Sainsbury’s and Asda merger, looking at the biggest challenges supermarkets have to face and the outlook for consumers. “Customers today enjoy having the luxury of…